Showing results (61-70 of 74) with videos related to
Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2025
Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826Sarah C Rutherford, Hongli Li, Alex F Herrera, et al.Human Pathology|August 6, 2014
BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphomaSamantha L Kendrick, Lucas Redd, Andrea Muranyi, et al.Blood|June 29, 2012
A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphomaAnamarija M Perry, Teresa M Cardesa-Salzmann, Paul N Meyer, et al.Cancer|December 19, 2025
Characterization of chromosome 5 aberrations in TP53 mutated myeloid neoplasms with ≥5% blasts: An International TP53 Investigators Network (iTiN) studyIrfan Yasin, Anna Stengel, Haipeng Shao, et al.Blood Cancer Discovery|March 11, 2025
Selective Enhancer Dependencies in MYC-Intact and MYC-Rearranged Germinal Center B-cell Diffuse Large B-cell LymphomaAshwin R Iyer, Aishwarya Gurumurthy, Shih-Chun A Chu, et al.Blood Cancer Discovery|June 27, 2025
DLBCL cells emerge post CD19 CAR-T with cross-antigen resistance and a gene signature predictive of clinical CAR-T responseFabiana Lϋӧnd, Jeanne Whalen, Youngchul Song, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2013
Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOPXin Huang, Bin Meng, Javeed Iqbal, et al.Oncoimmunology|August 7, 2024
DNA mismatch repair defect and intratumor heterogeneous deficiency differently impact immune responses in diffuse large B-cell lymphomaZijun Y Xu-Monette, Cancan Luo, Li Yu, et al.Cancer Immunology Research|September 21, 2022
Preclinical Characterization and Phase I Study of an Anti-HER2-TLR7 Immune-Stimulator Antibody Conjugate in Patients with HER2+ MalignanciesFilip Janku, Sae-Won Han, Toshihiko Doi, et al.The Journal of Clinical Investigation|May 8, 2019
G-CSF partially mediates effects of sleeve gastrectomy on the bone marrow nicheZiru Li, Julie Hardij, Simon S Evers, et al.Pageof 8